176 related articles for article (PubMed ID: 32816351)
1. Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: A phase II clinical trial.
Nishida Y; Hamada S; Urakawa H; Ikuta K; Sakai T; Koike H; Ito K; Emoto R; Ando Y; Matsui S
Cancer Sci; 2020 Nov; 111(11):4187-4194. PubMed ID: 32816351
[TBL] [Abstract][Full Text] [Related]
2. Low-dose chemotherapy with methotrexate and vinblastine for patients with desmoid tumors: relationship to CTNNB1 mutation status.
Nishida Y; Tsukushi S; Urakawa H; Hamada S; Kozawa E; Ikuta K; Ando Y; Ishiguro N
Int J Clin Oncol; 2015 Dec; 20(6):1211-7. PubMed ID: 25899770
[TBL] [Abstract][Full Text] [Related]
3. Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI.
Ingley KM; Burtenshaw SM; Theobalds NC; White LM; Blackstein ME; Gladdy RA; Thipphavong S; Gupta AA
Cancer Med; 2019 Sep; 8(11):5047-5057. PubMed ID: 31301110
[TBL] [Abstract][Full Text] [Related]
4. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial.
Skapek SX; Ferguson WS; Granowetter L; Devidas M; Perez-Atayde AR; Dehner LP; Hoffer FA; Speights R; Gebhardt MC; Dahl GV; Grier HE;
J Clin Oncol; 2007 Feb; 25(5):501-6. PubMed ID: 17290057
[TBL] [Abstract][Full Text] [Related]
5. Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis.
Palassini E; Frezza AM; Mariani L; Lalli L; Colombo C; Fiore M; Messina A; Casale A; Morosi C; Collini P; Stacchiotti S; Casali PG; Gronchi A
Cancer J; 2017; 23(2):86-91. PubMed ID: 28410293
[TBL] [Abstract][Full Text] [Related]
6. Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.
Toulmonde M; Pulido M; Ray-Coquard I; Andre T; Isambert N; Chevreau C; Penel N; Bompas E; Saada E; Bertucci F; Lebbe C; Le Cesne A; Soulie P; Piperno-Neumann S; Sweet S; Cecchi F; Hembrough T; Bellera C; Kind M; Crombe A; Lucchesi C; Le Loarer F; Blay JY; Italiano A
Lancet Oncol; 2019 Sep; 20(9):1263-1272. PubMed ID: 31331699
[TBL] [Abstract][Full Text] [Related]
7. Advanced aggressive fibromatosis: Effective palliation with chemotherapy.
Constantinidou A; Jones RL; Scurr M; Al-Muderis O; Judson I
Acta Oncol; 2011 Apr; 50(3):455-61. PubMed ID: 20799916
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children.
Skapek SX; Hawk BJ; Hoffer FA; Dahl GV; Granowetter L; Gebhardt MC; Ferguson WS; Grier HE
J Clin Oncol; 1998 Sep; 16(9):3021-7. PubMed ID: 9738571
[TBL] [Abstract][Full Text] [Related]
9. [Low-dose methotrexate combined with vinorelbine for inoperable desmoid tumor: efficacy and the prognostic factors].
Fan Z; Li S; Fang Z; Liu J; Bai C; Xue R; Zhang L; Gao T
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):39-43. PubMed ID: 26806736
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
Shimizu K; Hamada S; Sakai T; Koike H; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 Apr; 50(4):419-424. PubMed ID: 31845730
[TBL] [Abstract][Full Text] [Related]
11. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis.
Azzarelli A; Gronchi A; Bertulli R; Tesoro JD; Baratti D; Pennacchioli E; Dileo P; Rasponi A; Ferrari A; Pilotti S; Casali PG
Cancer; 2001 Sep; 92(5):1259-64. PubMed ID: 11571741
[TBL] [Abstract][Full Text] [Related]
12. Successful low-dose chemotherapy using vinblastine and methotrexate for the treatment of an ileoanal pouch mesenteric desmoid tumor: report of a case.
Kono T; Tomita I; Chisato N; Matsuda M; Kakisaka A; Kasai S
Dis Colon Rectum; 2004 Feb; 47(2):246-9. PubMed ID: 15043298
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Metronomic Therapy as a Low-Cost, Sustainable, Standard-of-Care Option in Desmoid Fibromatosis: Real-World Data From a Tertiary Care Center in India.
Bajpai J; Munot P; Kota K; Gupta G; Gala K; Gulia A; Rekhi B; Khanna N; Shetty N; Bhargava P; Srinivas S; Ostwal V; Patil V; Noronha V; Kulkarni S; Laskar S; Prabhash K; Chinnaswamy G; Gupta S; Banavali S
JCO Glob Oncol; 2024 May; 10():e2300308. PubMed ID: 38723218
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy with methotrexate and vinblastine for surgically unresectable, aggressive fibromatosis.
Park KH; Choi YJ; Kim KW; Ro KH; Kang CH; Song SH; Park JH
Jpn J Clin Oncol; 2016 Sep; 46(9):845-9. PubMed ID: 27365524
[TBL] [Abstract][Full Text] [Related]
15. Therapy of desmoid tumors and fibromatosis using vinorelbine.
Weiss AJ; Horowitz S; Lackman RD
Am J Clin Oncol; 1999 Apr; 22(2):193-5. PubMed ID: 10199460
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG).
Garbay D; Le Cesne A; Penel N; Chevreau C; Marec-Berard P; Blay JY; Debled M; Isambert N; Thyss A; Bompas E; Collard O; Salas S; Coindre JM; Bui B; Italiano A
Ann Oncol; 2012 Jan; 23(1):182-186. PubMed ID: 21444357
[TBL] [Abstract][Full Text] [Related]
17. Effective treatment of multifocal aggressive fibromatosis with low-dose chemotherapy.
Caglar K; Ozyönüm H; Akalin M; Balci S
Turk J Pediatr; 2006; 48(4):365-8. PubMed ID: 17290575
[TBL] [Abstract][Full Text] [Related]
18. Low-dose chemotherapy with vinblastine and methotrexate in childhood desmoid tumors.
Reich S; Overberg-Schmidt US; Bührer C; Henze G
J Clin Oncol; 1999 Mar; 17(3):1086. PubMed ID: 10071306
[No Abstract] [Full Text] [Related]
19. [Facial infantile aggressive fibromatosis: a frequent localization of an exceptional tumor!].
Bouguila J; Khonsari RH; Zitouni K; Zairi I; Adouani A
Ann Chir Plast Esthet; 2012 Jun; 57(3):304-7. PubMed ID: 20561731
[TBL] [Abstract][Full Text] [Related]
20. Long-term Outcomes of Oral Vinorelbine in Advanced, Progressive Desmoid Fibromatosis and Influence of
Mir O; Honoré C; Chamseddine AN; Dômont J; Dumont SN; Cavalcanti A; Faron M; Rimareix F; Haddag-Miliani L; Le Péchoux C; Levy A; Court C; Briand S; Fadel E; Mercier O; Bayle A; Brunet A; Ngo C; Rouleau E; Adam J; Le Cesne A
Clin Cancer Res; 2020 Dec; 26(23):6277-6283. PubMed ID: 32873570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]